A new issue of the Journal of Commercial Biotechnology has just been posted. Drop me a line if you would like to make a submission.
Volume 13, Issue 4
Editorial
| Editorial | |
| Neil Henderson |
Articles
| Is ‘evergreening’ a cause for concern? A legal perspective | |
| Scott Parker, Kevin Mooney |
| Exploiting the business opportunities in biotech connections: The power of social networks | |
| Ian P McCarthy, Leyland Pitt, Colin Campbell, Rian van der Merwe, Esmail Salehi-Sangeri |
| The roles and responsibilities of the EU qualified person for pharmacovigilance under Volume IXa March 2007 | |
| Graeme Ladds |
| Investing in new medical technologies: A decision framework | |
| Emma Cosh, Alan Girling, Richard Lilford, Helen McAteer, Terry Young |
| Innovative capabilities and strategic alliances: Who is gaining what in the pharmaceutical industry? | |
| Marisa Ohba, Paulo N Figueiredo |
| Industrial enzymes in bioindustrial sector development: An Indian perspective | |
| Anuj Kumar Chandel, Ravinder Rudravaram, Linga Venkateswar Rao, Pogaku Ravindra, Mangamoori Lakshmi Narasu |
Legal and Regulatory Updates
| Legal and regulatory update | |
| Gerry Kamstra, John Wilkinson |
Book Reviews
| Book Review: The Economics of Biotechnology: Volumes I and II | |
| Iraj Daizadeh |
| Book Review: Global Governance of Food and Agriculture Industries | |
| Alan McHughen |
| Book Review: The International Politics of Genetically Modified Food: Diplomacy, Trade and Law | |
| Robert Paarlberg |
| Science Business: The Promise, the Reality and the Future of Biotech | |
| Weijun Li |